Oncternal Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2024 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Oncternal Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2024 to Q3 2024.
  • Oncternal Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 35.3 %.
Debt-to-equity, Quarterly (%)
Period Value YoY Chg Change % Date
Q3 2024 35.3 Sep 30, 2024
Q2 2024 25.7 Jun 30, 2024
Q1 2024 18.3 Mar 31, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.